Hua Liu
Direktor/Vorstandsmitglied bei Beijing Xiangxin Biotechnology Co., Ltd.
Aktive Positionen von Hua Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beijing Xiangxin Biotechnology Co., Ltd.
 Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Direktor/Vorstandsmitglied | 07.03.2019 | - |
Karriereverlauf von Hua Liu
Ehemalige bekannte Positionen von Hua Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TAI UNITED HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 08.01.2015 | 27.10.2017 |
| Vorstandsvorsitzender | 19.01.2016 | 08.06.2016 | |
| Donghai Securities Co., Ltd. (Broker) | Corporate Officer/Principal | 01.09.2014 | 01.11.2015 |
GTJA Innovation Investment Co. Ltd.
 GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Hua Liu
| Imperial College London | Graduate Degree |
| University of Cambridge | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistik
International
| China | 5 |
| Vereinigtes Königreich | 3 |
| Hong Kong | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 4 |
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAI UNITED HOLDINGS LIMITED | Finance |
| Private Unternehmen | 3 |
|---|---|
| Donghai Securities Co., Ltd. (Broker) | Finance |
GTJA Innovation Investment Co. Ltd.
GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Finance |
Beijing Xiangxin Biotechnology Co., Ltd.
Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Health Technology |
